Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Korean Journal of Family Medicine ; : 102-105, 2017.
Artigo em Inglês | WPRIM | ID: wpr-33725

RESUMO

Williams syndrome (OMIM #194050) is a rare, well-recognized, multisystemic genetic condition affecting approximately 1/7,500 individuals. There are no marked regional differences in the incidence of Williams syndrome. The syndrome is caused by a hemizygous deletion of approximately 28 genes, including ELN on chromosome 7q11.2. Prenatal-onset growth retardation, distinct facial appearance, cardiovascular abnormalities, and unique hypersocial behavior are among the most common clinical features. Here, we report the case of a patient referred to us with distinct facial features and intellectual disability, who was diagnosed with Williams syndrome at the age of 37 years. Our aim is to increase awareness regarding the diagnostic features and complications of this recognizable syndrome among adult health care providers. Williams syndrome is usually diagnosed during infancy or childhood, but in the absence of classical findings, such as cardiovascular anomalies, hypercalcemia, and cognitive impairment, the diagnosis could be delayed. Due to the multisystemic and progressive nature of the syndrome, accurate diagnosis is critical for appropriate care and screening for the associated morbidities that may affect the patient's health and well-being.


Assuntos
Adulto , Humanos , Anormalidades Cardiovasculares , Transtornos Cognitivos , Diagnóstico , Pessoal de Saúde , Hipercalcemia , Incidência , Deficiência Intelectual , Programas de Rastreamento , Síndrome de Williams
2.
Psychiatry Investigation ; : 427-433, 2016.
Artigo em Inglês | WPRIM | ID: wpr-74573

RESUMO

OBJECTIVE: ObjectiveaaWe evaluated the distribution of alpha-2A adrenergic receptor (ADRA2A) and catechol-o-methyltransferase (COMT) single nucleotide polymorphisms (SNPs) among ADHD subtypes and other homogeneous patient populations including treatment-resistant cases and patients with high symptom severity. METHODS: Methodsaa121 ADHD patients aged 6-18 years were included in the study. Diagnosis and subtypes designation were confirmed using the Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) and symptoms were evaluated using the Conners' Parent (CPRS) and Teacher Rating Scales (CTRS). The response to methylphenidate was assessed objectively using the Clinical Global Impression-Severity Scale (CGI-S) and Global Assessment of Functioning Scale (GAS) as well as the Continuous Performance (CPT) and Trail Making tests (TMT-A, B). Patients were genotyped for ADRA2A (rs1800544) and COMT (rs4680) SNPs by PCR/RFLP and compared to a gender-matched control group. RESULTS: Although there was no association of COMT (rs4680) SNP with symptoms or diagnosis, the ADRA2A polymorphism, low socioeconomic status (SES), and comorbid psychiatric diagnosis were all associated with poor response to methylphenidate in logistic regression analysis. CONCLUSION: Clinicians may consider adjuvant strategies when these negative factors are present to increase the success of tailored ADHD treatments in the future.


Assuntos
Humanos , Agendamento de Consultas , Transtorno do Deficit de Atenção com Hiperatividade , Catecol O-Metiltransferase , Diagnóstico , Variação Genética , Genética , Modelos Logísticos , Transtornos Mentais , Metilfenidato , Transtornos do Humor , Pais , Fenótipo , Polimorfismo de Nucleotídeo Único , Receptores Adrenérgicos alfa 2 , Esquizofrenia , Classe Social , Teste de Sequência Alfanumérica , Pesos e Medidas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA